Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China flag China · Delayed Price · Currency is CNY
23.75
-0.45 (-1.86%)
At close: Nov 17, 2026

SHA:688443 Revenue

Chongqing Genrix Biopharmaceutical had revenue of 624.70M CNY in the quarter ending September 30, 2026, with 285.23% growth. This brings the company's total for the last twelve months to 800.98M, up 255.73% year-over-year. In the year 2025, Chongqing Genrix Biopharmaceutical had annual revenue of 230.73M with 666.66% growth. That makes Chongqing Genrix Biopharmaceutical the 21,360th largest company in the world by revenue and 3,917th in China.

Revenue (ttm)
800.98M
Revenue Growth
+255.73%
P/S Ratio
11.08
Revenue / Employee
706.95K
Employees
1,133
Market Cap
8.71B

Revenue Chart

Revenue by Geography

  • Overseas 132.51M 57.4%
  • China 98.19M 42.6%
Fiscal year ended Dec 31, 2025 See the full SHA:688443 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025230.73M200.63M666.66%
Dec 31, 202430.09M28.88M2,384.11%
Dec 31, 20231.21M736.26K154.92%
Dec 31, 2022475.24K-38.72M-98.79%
Dec 31, 202139.19M38.10M3,502.99%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.